Genpact Limited (35G) - Net Assets
Based on the latest financial reports, Genpact Limited (35G) has net assets worth €2.54 Billion EUR (≈ $2.97 Billion USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€5.36 Billion ≈ $6.27 Billion USD) and total liabilities (€2.82 Billion ≈ $3.30 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Explore Genpact Limited cash conversion from operations to assess how effectively this company generates cash.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €2.54 Billion |
| % of Total Assets | 47.44% |
| Annual Growth Rate | 5.51% |
| 5-Year Change | 30.28% |
| 10-Year Change | 83.2% |
| Growth Volatility | 8.72 |
Genpact Limited - Net Assets Trend (2013–2024)
This chart illustrates how Genpact Limited's net assets have evolved over time, based on quarterly financial data. For live valuation and market cap data, see Genpact Limited (35G) total market value.
Annual Net Assets for Genpact Limited (2013–2024)
The table below shows the annual net assets of Genpact Limited from 2013 to 2024. Read Genpact Limited total liabilities for a breakdown of total debt and financial obligations.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €2.39 Billion ≈ $2.79 Billion |
+6.28% |
| 2023-12-31 | €2.25 Billion ≈ $2.63 Billion |
+23.12% |
| 2022-12-31 | €1.83 Billion ≈ $2.13 Billion |
-3.74% |
| 2021-12-31 | €1.90 Billion ≈ $2.22 Billion |
+3.43% |
| 2020-12-31 | €1.83 Billion ≈ $2.14 Billion |
+8.59% |
| 2019-12-31 | €1.69 Billion ≈ $1.97 Billion |
+20.30% |
| 2018-12-31 | €1.40 Billion ≈ $1.64 Billion |
-1.39% |
| 2017-12-31 | €1.42 Billion ≈ $1.66 Billion |
+10.68% |
| 2016-12-31 | €1.29 Billion ≈ $1.50 Billion |
-1.36% |
| 2015-12-31 | €1.30 Billion ≈ $1.52 Billion |
+1.50% |
| 2014-12-31 | €1.29 Billion ≈ $1.50 Billion |
-2.94% |
| 2013-12-31 | €1.32 Billion ≈ $1.55 Billion |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Genpact Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 141.7% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €1.24 Billion | 51.75% |
| Other Components | €1.15 Billion | 48.25% |
| Total Equity | €2.39 Billion | 100.00% |
Genpact Limited Competitors by Market Cap
The table below lists competitors of Genpact Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Shanghai RAAS Blood Products Co Ltd Class A
SHE:002252
|
$5.38 Billion |
|
BRF SA ADR
NYSE:BRFS
|
$5.38 Billion |
|
Perseus Mining Ltd
TO:PRU
|
$5.39 Billion |
|
Jfrog Ltd
NASDAQ:FROG
|
$5.39 Billion |
|
Oberbank AG
VI:OBS
|
$5.38 Billion |
|
Blue Owl Capital Corporation
NYSE:OBDC
|
$5.37 Billion |
|
Jiangsu Hoperun Software Co Ltd
SHE:300339
|
$5.37 Billion |
|
Kite Realty Group Trust
NYSE:KRG
|
$5.37 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Genpact Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 2,248,392,000 to 2,389,611,000, a change of 141,219,000 (6.3%).
- Net income of 513,670,000 contributed positively to equity growth.
- Dividend payments of 108,466,000 reduced retained earnings.
- Share repurchases of 252,671,000 reduced equity.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €513.67 Million | +21.5% |
| Dividends Paid | €108.47 Million | -4.54% |
| Share Repurchases | €252.67 Million | -10.57% |
| Other Changes | €-11.31 Million | -0.47% |
| Total Change | €- | 6.28% |
Book Value vs Market Value Analysis
This analysis compares Genpact Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.13x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 3.95x to 2.13x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | €7.39 | €29.20 | x |
| 2018-12-31 | €7.42 | €29.20 | x |
| 2019-12-31 | €8.88 | €29.20 | x |
| 2020-12-31 | €9.70 | €29.20 | x |
| 2021-12-31 | €10.09 | €29.20 | x |
| 2022-12-31 | €9.98 | €29.20 | x |
| 2023-12-31 | €12.53 | €29.20 | x |
| 2024-12-31 | €13.68 | €29.20 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Genpact Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 21.50%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 10.78%
- • Asset Turnover: 0.96x
- • Equity Multiplier: 2.09x
- Recent ROE (21.50%) is above the historical average (19.42%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | 17.37% | 10.77% | 0.79x | 2.03x | €97.44 Million |
| 2014 | 14.94% | 8.42% | 0.83x | 2.13x | €63.49 Million |
| 2015 | 18.39% | 9.74% | 0.88x | 2.14x | €109.38 Million |
| 2016 | 20.79% | 10.41% | 0.89x | 2.24x | €138.88 Million |
| 2017 | 18.32% | 9.53% | 0.79x | 2.42x | €118.44 Million |
| 2018 | 20.03% | 9.37% | 0.85x | 2.51x | €140.84 Million |
| 2019 | 18.05% | 8.66% | 0.79x | 2.64x | €135.96 Million |
| 2020 | 16.81% | 8.31% | 0.76x | 2.66x | €124.85 Million |
| 2021 | 19.47% | 9.19% | 0.81x | 2.62x | €179.73 Million |
| 2022 | 19.35% | 8.08% | 0.95x | 2.51x | €170.79 Million |
| 2023 | 28.08% | 14.10% | 0.93x | 2.14x | €406.42 Million |
| 2024 | 21.50% | 10.78% | 0.96x | 2.09x | €274.71 Million |
Industry Comparison
This section compares Genpact Limited's net assets metrics with peer companies in the Information Technology Services industry.
Industry Context
- Industry: Information Technology Services
- Average net assets among peers: $221,365,977
- Average return on equity (ROE) among peers: -38.94%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Genpact Limited (35G) | €2.54 Billion | 17.37% | 1.11x | $5.38 Billion |
| CLPS INC. DL-0001 (1UK) | $67.80 Million | 6.57% | 0.50x | $22.08 Million |
| Globant SA (2G2) | $1.79 Billion | 8.87% | 0.53x | $1.93 Billion |
| Solutions 30 SE (30L3) | $37.51 Million | 22.34% | 3.20x | $73.59 Million |
| NANOSPHERE (3NS) | $744.08K | -186.51% | 2.14x | $1.12 Million |
| CPT GLOBAL LTD (714) | $2.75 Million | 123.73% | 2.71x | $2.11 Million |
| PASSUS S.A. ZY-1 (71X) | $24.32 Million | 6.67% | 2.00x | $57.96 Million |
| REVEZ CORPORATION LTD. (7IQ) | $1.32 Million | -332.24% | 3.80x | $131.66K |
| XTM INC. (7XT) | $-7.33 Million | 0.00% | 0.00x | $1.23 Million |
| TPXIMPACT HOLDINGS LS-01 (9L7) | $78.56 Million | 0.12% | 0.60x | $35.61 Million |
About Genpact Limited
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers customer onboarding, customer service, collections, retail and commercial loan operations, payme… Read more